Calamos Advisors’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-255,799
Closed -$25.4M 846
2019
Q3
$25.4M Buy
255,799
+19,454
+8% +$1.85M 0.14% 205
2019
Q2
$21.8M Sell
236,345
-37,423
-14% -$3.55M 0.12% 218
2019
Q1
$25.8M Sell
273,768
-154,295
-36% -$13.5M 0.16% 188
2018
Q4
$27.4M Buy
428,063
+27,229
+7% +$2.01M 0.18% 167
2018
Q3
$35.9M Buy
400,834
+11,827
+3% +$1.05M 0.2% 137
2018
Q2
$30.9M Buy
389,007
+63,687
+20% +$5.29M 0.19% 147
2018
Q1
$29M Sell
325,320
-334,930
-51% -$32.2M 0.19% 150
2017
Q4
$68.9M Sell
660,250
-147,976
-18% -$16.7M 0.35% 45
2017
Q3
$118M Buy
808,226
+22,083
+3% +$3.01M 0.91% 14
2017
Q2
$102M Buy
786,143
+1,155
+0.1% +$142K 0.75% 20
2017
Q1
$97.7M Buy
784,988
+18,328
+2% +$2.19M 0.77% 21
2016
Q4
$88.7M Sell
766,660
-242,773
-24% -$27M 0.71% 27
2016
Q3
$106M Buy
1,009,433
+105,743
+12% +$11.4M 0.75% 21
2016
Q2
$89.1M Sell
903,690
-71,355
-7% -$7.38M 0.63% 31
2016
Q1
$97.6M Sell
975,045
-212,660
-18% -$21.9M 0.65% 29
2015
Q4
$142M Buy
1,187,705
+149,260
+14% +$17.3M 0.9% 19
2015
Q3
$112M Sell
1,038,445
-26,108
-2% -$3.24M 0.77% 23
2015
Q2
$123M Buy
1,064,553
+14,824
+1% +$1.69M 0.76% 23
2015
Q1
$121M Buy
1,049,729
+63,134
+6% +$7.54M 0.76% 23
2014
Q4
$110M Sell
986,595
-540,564
-35% -$57M 0.73% 27
2014
Q3
$145M Sell
1,527,159
-46,797
-3% -$4.22M 0.97% 20
2014
Q2
$135M Buy
1,573,956
+60,140
+4% +$4.57M 0.86% 28
2014
Q1
$106M Sell
1,513,816
-328,246
-18% -$26M 0.68% 38
2013
Q4
$156M Sell
1,842,062
-137,410
-7% -$10.9M 0.99% 22
2013
Q3
$152M Buy
1,979,472
+516,322
+35% +$36.2M 0.96% 27
2013
Q2
$85.5M Buy
+1,463,150
New +$88M 0.56% 50

Other funds holding CELG

Calamos Advisors's CELG Position: Q4 2019 in Review

Calamos Advisors sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 255,799 shares — an estimated $25.4M sold.

Calamos Advisors first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $156M in Q4 2013. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Calamos Advisors reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Calamos Advisors sold 255,799 Celgene Corp shares in Q4 2019, an estimated $25.4M.
  • Calamos Advisors first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Calamos Advisors's Celgene Corp position peaked at $156M in Q4 2013.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Calamos Advisors's 13F filing for Q4 2019, filed 15 Jan 2020.